Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation

Adam Doyle; Oyedele Adeyi; Korosh Khalili; Sandra Fischer; Martin Dib; Nicolas Goldaracena; Jayne Dillon; David Grant; Mark Cattral; Ian McGilvray; Paul Greig; Anand Ghanekar; Leslie Lilly; Eberhard Renner; Gary Levy; Nazia Selzner

doi:10.1002/lt.24495

Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation

Adam Doyle, Oyedele Adeyi, Korosh Khalili, Sandra Fischer, Martin Dib, Nicolas Goldaracena, Jayne Dillon, David Grant, Mark Cattral, Ian McGilvray, Paul Greig, Anand Ghanekar, Leslie Lilly, Eberhard Renner, Gary Levy, Nazia Selzner

Research output: Contribution to journal › Letter › peer-review

26 Scopus citations

Original language	English (US)
Pages (from-to)	1295-1300
Number of pages	6
Journal	Liver Transplantation
Volume	22
Issue number	9
DOIs	https://doi.org/10.1002/lt.24495
State	Published - Sep 1 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1002/lt.24495

OpenUrl availability

Full text

Cite this

Doyle, A., Adeyi, O., Khalili, K., Fischer, S., Dib, M., Goldaracena, N., Dillon, J., Grant, D., Cattral, M., McGilvray, I., Greig, P., Ghanekar, A., Lilly, L., Renner, E., Levy, G., & Selzner, N. (2016). Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation. Liver Transplantation, 22(9), 1295-1300. https://doi.org/10.1002/lt.24495

Doyle, A, Adeyi, O, Khalili, K, Fischer, S, Dib, M, Goldaracena, N, Dillon, J, Grant, D, Cattral, M, McGilvray, I, Greig, P, Ghanekar, A, Lilly, L, Renner, E, Levy, G & Selzner, N 2016, 'Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation', Liver Transplantation, vol. 22, no. 9, pp. 1295-1300. https://doi.org/10.1002/lt.24495

@article{2172124b667d42fab8b2b7522ccea993,

title = "Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation",

author = "Adam Doyle and Oyedele Adeyi and Korosh Khalili and Sandra Fischer and Martin Dib and Nicolas Goldaracena and Jayne Dillon and David Grant and Mark Cattral and Ian McGilvray and Paul Greig and Anand Ghanekar and Leslie Lilly and Eberhard Renner and Gary Levy and Nazia Selzner",

year = "2016",

month = sep,

day = "1",

doi = "10.1002/lt.24495",

language = "English (US)",

volume = "22",

pages = "1295--1300",

journal = "Liver Transplantation",

issn = "1527-6465",

publisher = "John Wiley and Sons Ltd",

number = "9",

}

TY - JOUR

T1 - Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation

AU - Doyle, Adam

AU - Adeyi, Oyedele

AU - Khalili, Korosh

AU - Fischer, Sandra

AU - Dib, Martin

AU - Goldaracena, Nicolas

AU - Dillon, Jayne

AU - Grant, David

AU - Cattral, Mark

AU - McGilvray, Ian

AU - Greig, Paul

AU - Ghanekar, Anand

AU - Lilly, Leslie

AU - Renner, Eberhard

AU - Levy, Gary

AU - Selzner, Nazia

PY - 2016/9/1

Y1 - 2016/9/1

UR - http://www.scopus.com/inward/record.url?scp=84983488992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983488992&partnerID=8YFLogxK

U2 - 10.1002/lt.24495

DO - 10.1002/lt.24495

M3 - Letter

C2 - 27314458

AN - SCOPUS:84983488992

SN - 1527-6465

VL - 22

SP - 1295

EP - 1300

JO - Liver Transplantation

JF - Liver Transplantation

IS - 9

ER -

Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this